Status:
UNKNOWN
Magnetic Resonance Imaging for Lung Radiotherapy
Lead Sponsor:
The Clatterbridge Cancer Centre NHS Foundation Trust
Conditions:
Cancer
Lung Cancer
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the use of Magnetic Resonance Imaging (MRI) in the diagnostic and planning phase of radiotherapy for lung cancer and then introduce it into on-treatment ima...
Detailed Description
Firstly, 3 stage III NSCLC patients receiving radiotherapy will be imaged, each for a single MRI session using TWIST and HASTE sequences. Initial sequence parameters will be those determined during th...
Eligibility Criteria
Inclusion
- This study will recruit patients due to have radical external beam radiotherapy as per standard institutional practice.
- The criteria specified in the institutional protocol are:
- Histologically verified NSCLC or presumed not histologically verified but MDT reviewed and agreed if obtaining biopsy is considered too risky
- Stage II, IIIA \& IIIB (AJCC, 7th Edition TNM), fully staged with CT, PET-CT +/-EBUS for mediastinal staging
- WHO performance status ≤ 2
- Adequate respiratory function
- Absence of malignant effusion
- Aged 18 and over
Exclusion
- Under 18 years or age
- Patients not able to have radical radiotherapy
- Pregnant or lactating women
- Unable to give informed consent
Key Trial Info
Start Date :
May 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04275921
Start Date
May 16 2018
End Date
April 30 2022
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clatterbridge Cancer Centre NHS Foundation Trust
Bebington, United Kingdom, CH634JY